Other Viruses Citation List: February 27 - March 12, 2015

Hepatitis B Virus

1. MicroRNA-130a Can Inhibit Hepatitis B Virus Replication via Targeting PGC1alpha and PPARgamma. Huang, J.Y., S.F. Chou, J.W. Lee, H.L. Chen, C.M. Chen, M.H. Tao, and C. Shih. RNA, 2015. 21(3): p. 385-400. PMID[25595716].

[PubMed]. OV_0227-031215.

2. Design and Synthesis of a Novel Candidate Compound NTI-007 Targeting Sodium Taurocholate Cotransporting Polypeptide [NTCP]-APOA1-Hbx-Beclin1-mediated Autophagic Pathway in HBV Therapy. Zhang, J., L.L. Fu, M. Tian, H.Q. Liu, J.J. Li, Y. Li, J. He, J. Huang, L. Ouyang, H.Y. Gao, and J.H. Wang. Bioorganic & Medicinal Chemistry, 2015. 23(5): p. 976-984. PMID[25650312].

[PubMed]. OV_0227-031215.

Hepatitis C Virus

3. Multi-parameter Optimization of AZA-follow-ups to BI 207524, a Thumb Pocket 1 HCV NS5B Polymerase Inhibitor. Part 2: Impact of Lipophilicity on Promiscuity and in Vivo Toxicity. Beaulieu, P.L., G. Bolger, D. Deon, M. Duplessis, G. Fazal, A. Gagnon, M. Garneau, S. LaPlante, T. Stammers, G. Kukolj, and J. Duan. Bioorganic & Medicinal Chemistry Letters, 2015. 25(5): p. 1140-1145. PMID[25599836].

[PubMed]. OV_0227-031215.

4. AZA Follow-ups to BI 207524, a Thumb Pocket 1 HCV NS5B Polymerase Inhibitor. Part 1: Mitigating the Genotoxic Liability of an Aniline Metabolite. Beaulieu, P.L., G. Bolger, M. Duplessis, A. Gagnon, M. Garneau, T. Stammers, G. Kukolj, and J. Duan. Bioorganic & Medicinal Chemistry Letters, 2015. 25(5): p. 1135-1139. PMID[25575656].

[PubMed]. OV_0227-031215.

5. SKI-1/S1P Inhibitor PF-429242 Impairs the Onset of HCV Infection. Blanchet, M., C. Sureau, C. Guevin, N.G. Seidah, and P. Labonte. Antiviral Research, 2015. 115: p. 94-104. PMID[25573299].

[PubMed]. OV_0227-031215.

6. Natural Compounds Isolated from Brazilian Plants are Potent Inhibitors of Hepatitis C Virus Replication in Vitro. Jardim, A.C., Z. Igloi, J.F. Shimizu, V.A. Santos, L.G. Felippe, B.F. Mazzeu, Y. Amako, M. Furlan, M. Harris, and P. Rahal. Antiviral Research, 2015. 115: p. 39-47. PMID[25557602].

[PubMed]. OV_0227-031215.

7. In Vitro Activity and Resistance Profile of Dasabuvir, a Nonnucleoside Hepatitis C Virus Polymerase Inhibitor. Kati, W., G. Koev, M. Irvin, J. Beyer, Y. Liu, P. Krishnan, T. Reisch, R. Mondal, R. Wagner, A. Molla, C. Maring, and C. Collins. Antimicrobial Agents and Chemotherapy, 2015. 59(3): p. 1505-1511. PMID[25534735].

[PubMed]. OV_0227-031215.

8. Synthesis and Characterization of 1'-C-Cyano-2'-fluoro-2'-C-methyl pyrimidine Nucleosides as HCV Polymerase Inhibitors. Kirschberg, T.A., M.R. Mish, L. Zhang, N.H. Squires, K.Y. Wang, A. Cho, J.Y. Feng, M. Fenaux, D. Babusis, Y. Park, A.S. Ray, and C.U. Kim. Bioorganic & Medicinal Chemistry Letters, 2015. 25(5): p. 1046-1049. PMID[25650256].

[PubMed]. OV_0227-031215.

9. Saikosaponin b2 Is a Naturally Occurring Terpenoid That Efficiently Inhibits Hepatitis C Virus Entry. Lin, L.T., C.Y. Chung, W.C. Hsu, S.P. Chang, T.C. Hung, J. Shields, R.S. Russell, C.C. Lin, C.F. Li, M.H. Yen, D.L. Tyrrell, C.C. Lin, and C.D. Richardson. Journal of Hepatology, 2015. 62(3): p. 541-548. PMID[25450204].

[PubMed]. OV_0227-031215.

10. Linear and Branched Alkyl-esters and Amides of Gallic acid and Other (Mono-, Di- and Tri-) Hydroxy benzoyl Derivatives as Promising anti-HCV Inhibitors. Rivero-Buceta, E., P. Carrero, E.G. Doyaguez, A. Madrona, E. Quesada, M.J. Camarasa, M.J. Perez-Perez, P. Leyssen, J. Paeshuyse, J. Balzarini, J. Neyts, and A. San-Felix. European Journal of Medicinal Chemistry, 2015. 92: p. 656-671. PMID[25617695].

[PubMed]. OV_0227-031215.

11. Dasabuvir : A New Direct Antiviral Agent for the Treatment of Hepatitis C. Trivella, J.P., J. Gutierrez, and P. Martin. Expert Opinion on Pharmacotherapy, 2015. 16(4): p. 617-624. PMID[25665437].

[PubMed]. OV_0227-031215.

12. Synergy of Entry Inhibitors with Direct-acting Antivirals Uncovers Novel Combinations for Prevention and Treatment of Hepatitis C. Xiao, F., I. Fofana, C. Thumann, L. Mailly, R. Alles, E. Robinet, N. Meyer, M. Schaeffer, F. Habersetzer, M. Doffoel, P. Leyssen, J. Neyts, M.B. Zeisel, and T.F. Baumert. Gut, 2015. 64(3): p. 483-494. PMID[24848265].

[PubMed]. OV_0227-031215.

13. LC-ESI-MS/MS Analysis and Pharmacokinetics of GP205, an Innovative Potent Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease in Rats. Yang, N., Q. Sun, Z. Xu, X. Wang, X. Zhao, Y. Cao, L. Chen, and G. Fan. Molecules, 2015. 20(3): p. 4319-4336. PMID[25756650].

[PubMed]. OV_0227-031215.

Human Cytomegalovirus

14. A High-affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types. Kauvar, L.M., K. Liu, M. Park, N. DeChene, R. Stephenson, E. Tenorio, S.L. Ellsworth, T. Tabata, M. Petitt, M. Tsuge, J. Fang-Hoover, S.P. Adler, X. Cui, M.A. McVoy, and L. Pereira. Antimicrobial Agents and Chemotherapy, 2015. 59(3): p. 1558-1568. PMID[25534746].

[PubMed]. OV_0227-031215.

Herpes Simplex Virus 1

15. Anti-herpes Simplex Virus Activity of Polysaccharides from Eucheuma gelatinae. Jin, F., C. Zhuo, Z. He, H. Wang, W. Liu, R. Zhang, and Y. Wang. World Journal of Microbiology & Biotechnology, 2015. 31(3): p. 453-460. PMID[25604263].

[PubMed]. OV_0227-031215.

16. Anti-HSV1 Activity of Brown Algal Polysaccharides and Possible Relevance to the Treatment of Alzheimer's Disease. Wozniak, M., T. Bell, A. Denes, R. Falshaw, and R. Itzhaki. International Journal of Biological Macromolecules, 2015. 74: p. 530-540. PMID[25583021].

[PubMed]. OV_0227-031215.

Citations from the ISI Web of Knowledge Listings for O.V.

17. Inhibitory Effects of Pinus massoniana Bark Extract on Hepatitis C Virus in Vitro. Wang, C.F., L.F. Zhang, P. Cheng, and Q. Zhang. Pharmaceutical Biology, 2015. 53(3): p. 451-456. ISI[000348831200020].

[WOS]. OV_0227-031215.